Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from IDT Australia Limited ( (AU:IDT) ).
IDT Australia Limited reported an 83% increase in revenues to $10.5 million for the half-year ended December 31, 2024, but the company saw a reduced loss after tax of $3.3 million, down 15.8% from the previous year. This improvement in financial performance indicates a positive trajectory for IDT Australia, although the company did not declare any dividends for the period, reflecting ongoing financial prudence amidst recovery efforts.
More about IDT Australia Limited
IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacture of pharmaceutical products and services.
YTD Price Performance: 4.55%
Average Trading Volume: 146,501
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$47.55M
For detailed information about IDT stock, go to TipRanks’ Stock Analysis page.
